Old Web
English
Sign In
Acemap
>
authorDetail
>
Amy M. Ford
Amy M. Ford
Eli Lilly and Company
Endocrinology
Internal medicine
FGF21
Genetically modified mouse
Diabetes mellitus
4
Papers
2037
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
2013
PLOS ONE
Alexei Kharitonenkov
John Michael Beals
Radmila Micanovic
Beth Ann Strifler
Radhakrishnan Rathnachalam
Victor J. Wroblewski
Shun Li
Anja Koester
Amy M. Ford
Tamer Coskun
James D. Dunbar
Christine C. Cheng
Christopher C. Frye
Thomas Frank Bumol
David E. Moller
Show All
Source
Cite
Save
Citations (115)
FGF-21 as a novel metabolic regulator
2005
Journal of Clinical Investigation
Alexei Kharitonenkov
Tatiyana L. Shiyanova
Anja Koester
Amy M. Ford
Radmila Micanovic
Elizabeth Galbreath
George E. Sandusky
Lisa Janine Hammond
Julie S. Moyers
Rebecca A. Owens
Jesper Gromada
Joseph T. Brozinick
Eric Hawkins
Victor J. Wroblewski
De-Shan Li
Farrokh Mehrbod
S. Richard Jaskunas
Armen B. Shanafelt
Show All
Source
Cite
Save
Citations (1535)
Cecal ligation and puncture with total parenteral nutrition: A clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness
2004
Journal of Surgical Research
Josef G. Heuer
Dianna L. Bailey
Ganesh R. Sharma
Tonghai Zhang
Chunjin Ding
Amy M. Ford
Eddie J. Stephens
Kimberly C. Holmes
Renee L. Grubbs
Kelly A. Fynboe
Yun-Fei Chen
Joseph A. Jakubowski
Show All
Source
Cite
Save
Citations (30)
1